Hetlioz (Vanda Pharmaceuticals Inc.)
Welcome to the PulseAid listing for the Hetlioz drug offered from Vanda Pharmaceuticals Inc.. This Melatonin Receptor Agonist [EPC],Melatonin Receptor Agonists [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Vanda Pharmaceuticals Inc. |
NON-PROPRIETARY NAME: | tasimelteon |
SUBSTANCE NAME: | TASIMELTEON |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Melatonin Receptor Agonist [EPC],Melatonin Receptor Agonists [MoA] |
ROUTE: | ORAL |
DOSAGE FORM: | CAPSULE |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2014-04-04 |
END MARKETING DATE: | 0000-00-00 |
Hetlioz HUMAN PRESCRIPTION DRUG Details:
Item Description | Hetlioz from Vanda Pharmaceuticals Inc. |
LABELER NAME: | Vanda Pharmaceuticals Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 20(mg/1) |
START MARKETING DATE: | 2014-04-04 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 43068-220_9dfa71b8-de12-491a-82cd-7ebb8a6f2823 |
PRODUCT NDC: | 43068-220 |
APPLICATION NUMBER: | NDA205677 |
Other TASIMELTEON Pharmaceutical Manufacturers / Labelers: